找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Kidney Disease in the Cardiac Catheterization Laboratory; A Practical Approach Janani Rangaswami,Edgar V. Lerma,Peter A. McCullou Book 2020

[復制鏈接]
樓主: centipede
11#
發(fā)表于 2025-3-23 10:30:22 | 只看該作者
12#
發(fā)表于 2025-3-23 16:35:03 | 只看該作者
13#
發(fā)表于 2025-3-23 20:25:10 | 只看該作者
14#
發(fā)表于 2025-3-24 00:25:38 | 只看該作者
Peripheral Arterial Disease in Chronic Kidney Disease: Disease Burden, Outcomes, and Interventional patients with chronic kidney disease (CKD). PAD is particularly common in those with severe CKD, and early detection and effective treatment of PAD is indicated in those with CKD and concomitant PAD. Measurement of the ankle-brachial index is a simple, reliable, and noninvasive test to diagnose PAD
15#
發(fā)表于 2025-3-24 03:03:22 | 只看該作者
Cardiovascular Impact of Atherosclerotic Renovascular Diseaseich activates the renin-angiotensin-aldosterone system and increases a variety of inflammatory and pro-fibrotic cytokines. This results in the development of hypertension and a decline in renal function. Unfortunately the finding of renal artery stenosis does not always imply the presence of renal i
16#
發(fā)表于 2025-3-24 08:23:50 | 只看該作者
Therapeutic Considerations with Revascularization in Chronic Kidney Disease: Radial Versus Femoral Atable settings. Recent evidence suggests potential nephroprotective benefits of the radial approach over the femoral route toward both short- and long-term kidney injury preventions. Acute kidney injury (AKI) after cardiac catheterization remains a major issue in hospitalized patients and is associa
17#
發(fā)表于 2025-3-24 10:59:22 | 只看該作者
Antiplatelet Agent Choice and Platelet Function Testing in CKD of the platelet COX-1 enzyme by aspirin and the P2Y.-ADP interaction by P2Y. receptor inhibitors is a major pharmacologic strategy to prevent acute as well as long-term thrombotic event occurrences following PCI. Clopidogrel, the most widely used P2Y. receptor inhibitor, is associated with wide res
18#
發(fā)表于 2025-3-24 16:35:22 | 只看該作者
Choice of Stents and Clinical Outcomes in Patients with Chronic Kidney Diseases (ST) following percutaneous coronary intervention (PCI). However, patients with chronic kidney disease (CKD) are characterized by unique risk factors that ought to be considered when selecting a coronary stent. In addition to the systemic risk factors in patients with CKD, atherosclerotic lesions
19#
發(fā)表于 2025-3-24 22:20:37 | 只看該作者
Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Interventions Versus Cis associated with the development and progression of atherosclerotic cardiovascular disease. In addition to traditional cardiovascular risk factors such as hypertension, smoking, diabetes mellitus, and hyperlipidemia, patients with CKD also carry nontraditional risk factors such as increased vascul
20#
發(fā)表于 2025-3-25 02:54:32 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 15:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
湄潭县| 濮阳市| 甘孜县| 偏关县| 凯里市| 峨山| 南郑县| 新龙县| 朝阳县| 周至县| 安岳县| 扎鲁特旗| 浮山县| 许昌县| 千阳县| 阜城县| 伊吾县| 肥城市| 无极县| 三亚市| 开原市| 宜城市| 灵丘县| 顺义区| 望奎县| 察雅县| 满洲里市| 大竹县| 辽源市| 永安市| 马尔康县| 长治县| 蛟河市| 泰顺县| 昌乐县| 永顺县| 琼海市| 工布江达县| 分宜县| 鄯善县| 镇安县|